Similar articles

• The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.

  Avgerinos PC, Yanovski JA, Oldfield EH, Nieman LK, Cutler GB Jr. Avgerinos PC, et al. Ann Intern Med. 1994 Sep 1;121(5):318-27. doi: 10.7326/0003-4819-121-5-199409010-00002. Ann Intern Med. 1994. PMID: 8042820
• Performance of the 4-mg intravenous dexamethasone suppression test in differentiating Cushing disease from pseudo-Cushing syndrome.

  Nouvel M, Rabilloud M, Raverot V, Subtil F, Vouillarmet J, Thivolet C, Jouanneau E, Borson-Chazot F, Pugeat M, Raverot G. Nouvel M, et al. Ann Endocrinol (Paris). 2016 Feb;77(1):30-6. doi: 10.1016/j.ando.2015.11.001. Epub 2015 Dec 3. Ann Endocrinol (Paris). 2016. PMID: 26656734
• Diagnostic tests for children who are referred for the investigation of Cushing syndrome.

  Batista DL, Riar J, Keil M, Stratakis CA. Batista DL, et al. Pediatrics. 2007 Sep;120(3):e575-86. doi: 10.1542/peds.2006-2402. Epub 2007 Aug 13. Pediatrics. 2007. PMID: 17698579
• The biochemical investigation of Cushing syndrome.

  Simard M. Simard M. Neurosurg Focus. 2004 Apr 15;16(4):E4. Neurosurg Focus. 2004. PMID: 15191333 Review.
• Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories.

  Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Wood PJ, et al. Ann Clin Biochem. 1997 May;34 ( Pt 3):222-9. doi: 10.1177/000456329703400302. Ann Clin Biochem. 1997. PMID: 9158818 Review. No abstract available.